Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitoquines as Prognostic Factors of Exacerbations and Hospital Admission in COPD Patients.

NCT04449419 is registered in ClinicalTrials.gov with Hospital Universitario Marqués de Valdecilla as lead sponsor.

NCT NCT04449419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04449419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitoquines as Prognostic Factors of Exacerbations and Hospital Admission in COPD Patients.
Lead sponsor
Hospital Universitario Marqués de Valdecilla
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2020
Completion date
June 1, 2021
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation